TG Therapeutics, Inc. - stock earnings
TGTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -14.4 million USD | 44.0 million USD |
| 2023Q3 | 113.9 million USD | 165.8 million USD |
| 2023Q2 | -47.6 million USD | 16.1 million USD |
| 2023Q1 | -38.6 million USD | 7.8 million USD |
| 2022Q4 | -53.9 million USD | 80000 USD |
| 2022Q3 | -36.7 million USD | 94000 USD |
| 2022Q2 | -42.1 million USD | 594000 USD |
| 2022Q1 | -71.2 million USD | 2.0 million USD |
| 2021Q4 | -93.3 million USD | 2.3 million USD |
| 2021Q3 | -85.6 million USD | 2.0 million USD |
| 2021Q2 | -78.5 million USD | 1.5 million USD |
| 2021Q1 | -90.6 million USD | 793000 USD |
| 2020Q4 | -88.2 million USD | 38000 USD |
| 2020Q3 | -87.2 million USD | 38000 USD |
| 2020Q2 | -52.9 million USD | 38000 USD |
| 2020Q1 | -51.1 million USD | 38000 USD |
| 2019Q4 | -39.6 million USD | 38000 USD |
| 2019Q3 | -61.9 million USD | 38000 USD |
| 2019Q2 | -36.2 million USD | 38000 USD |
| 2019Q1 | -35.2 million USD | 38000 USD |
| 2018Q4 | -53.9 million USD | 38000 USD |
| 2018Q3 | -34.0 million USD | 38000 USD |
| 2018Q2 | -44.1 million USD | 38000 USD |
| 2018Q1 | -41.5 million USD | 38000 USD |
| 2017Q4 | -30.9 million USD | 38095 USD |
| 2017Q3 | -31.5 million USD | 38096 USD |
| 2017Q2 | -28.4 million USD | 38095 USD |
| 2017Q1 | -27.7 million USD | 38095 USD |
| 2016Q4 | -23.7 million USD | 38095 USD |
| 2016Q3 | -24.8 million USD | 38096 USD |
| 2016Q2 | -15.9 million USD | 38095 USD |
| 2016Q1 | -13.8 million USD | 38095 USD |
| 2015Q4 | -17.6 million USD | 38095 USD |
| 2015Q3 | -13.7 million USD | 38096 USD |
| 2015Q2 | -17.1 million USD | 38095 USD |
| 2015Q1 | -14.6 million USD | 38095 USD |
| 2014Q4 | -18.8 million USD | 38095 USD |
| 2014Q3 | -17.5 million USD | 38096 USD |
| 2014Q2 | -12.0 million USD | 38095 USD |
| 2014Q1 | -7.5 million USD | 38095 USD |
| 2013Q4 | -5.7 million USD | 38095 USD |
| 2013Q3 | -4.6 million USD | 38096 USD |
| 2013Q2 | -6.6 million USD | 38095 USD |
| 2013Q1 | -3.7 million USD | 38095 USD |
| 2012Q4 | -3.5 million USD | 19048 USD |
| 2012Q3 | -2.5 million USD | ? USD |
| 2012Q2 | -1.9 million USD | ? USD |
| 2012Q1 | -10.3 million USD | ? USD |
| 2011Q4 | -1.2 million USD | ? USD |
| 2011Q3 | -551739 USD | ? USD |
| 2011Q2 | -3.0 million USD | ? USD |
| 2011Q1 | 3.8 million USD | ? USD |
| 2010Q4 | 365231 USD | ? USD |
| 2010Q3 | 41247 USD | ? USD |
| 2010Q2 | 1.9 million USD | ? USD |
| 2010Q1 | -1.6 million USD | ? USD |
| 2009Q4 | -222913 USD | ? USD |
| 2009Q3 | -416089 USD | ? USD |
| 2009Q2 | -1.4 million USD | ? USD |
| 2009Q1 | -761844 USD | ? USD |
| 2008Q4 | 127019 USD | ? USD |
| 2008Q3 | -1.4 million USD | ? USD |
| 2008Q2 | -1.4 million USD | ? USD |
| 2008Q1 | -1.6 million USD | ? USD |
| 2007Q4 | -1.9 million USD | ? USD |
| 2007Q3 | -2.7 million USD | ? USD |
| 2007Q2 | -4.9 million USD | ? USD |
| 2007Q1 | -3.1 million USD | -69810 USD |
| 2006Q4 | -3.1 million USD | ? USD |
| 2006Q3 | -1.9 million USD | ? USD |
| 2006Q2 | -2.3 million USD | ? USD |
| 2006Q1 | -2.8 million USD | ? USD |
| 2005Q4 | -2.5 million USD | ? USD |
| 2005Q3 | -1.8 million USD | ? USD |
| 2005Q2 | -13.4 million USD | ? USD |
| 2005Q1 | -1.4 million USD | ? USD |
| 2004Q4 | -1.7 million USD | ? USD |
| 2004Q3 | -2.2 million USD | ? USD |
| 2004Q2 | -861606 USD | ? USD |
| 2004Q1 | -1.1 million USD | ? USD |
| 2003Q4 | -1.5 million USD | ? USD |
| 2003Q3 | -3.3 million USD | ? USD |
| 2003Q2 | -776318 USD | ? USD |
| 2003Q1 | -370681 USD | ? USD |
| 2002Q4 | -370681 USD | 500000 USD |
| 2002Q3 | -586414 USD | ? USD |
| 2002Q2 | 34234 USD | 500000 USD |
| 2002Q1 | -565152 USD | ? USD |
| 2001Q4 | -565152 USD | 2.7 million USD |
| 2001Q3 | -735562 USD | ? USD |
| 2001Q2 | -2.1 million USD | 1 USD |
| 2001Q1 | -364452 USD | 1.9 million USD |
| 2000Q4 | -364452 USD | 1.9 million USD |
| 2000Q3 | -972426 USD | 1.1 million USD |
| 2000Q2 | -3.1 million USD | 1.4 million USD |
| 2000Q1 | -1.4 million USD | 925490 USD |
| 1999Q4 | -600000 USD | 900000 USD |
| 1999Q3 | -300000 USD | 300000 USD |
| 1999Q2 | -600000 USD | 100000 USD |
| 1999Q1 | -900000 USD | 100000 USD |
| 1998Q4 | -1.3 million USD | 500000 USD |
| 1998Q3 | -1.2 million USD | 100000 USD |
| 1998Q2 | 1.0 million USD | 2.5 million USD |
| 1998Q1 | -1.3 million USD | 100000 USD |
| 1997Q4 | -1.5 million USD | ? USD |
| 1997Q3 | -1.0 million USD | 100000 USD |
| 1997Q2 | -1.8 million USD | 100000 USD |
| 1997Q1 | -900000 USD | 100000 USD |
| 1996Q4 | -1.0 million USD | ? USD |
| 1996Q3 | -1.1 million USD | 100000 USD |
| 1996Q2 | -800000 USD | 100000 USD |
| 1996Q1 | -800000 USD | 100000 USD |
TGTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 12.7 million USD | 233.7 million USD |
| 2022 | -203.8 million USD | 2.8 million USD |
| 2021 | -355.6 million USD | 6.7 million USD |
| 2020 | -285.9 million USD | 152000 USD |
| 2019 | -179.3 million USD | 152000 USD |
| 2018 | -173.5 million USD | 152000 USD |
| 2017 | -118.5 million USD | 152381 USD |
| 2016 | -78.3 million USD | 152381 USD |
| 2015 | -62.9 million USD | 152381 USD |
| 2014 | -55.8 million USD | 152381 USD |
| 2013 | -20.5 million USD | 152381 USD |
| 2012 | -18.1 million USD | 19048 USD |
| 2011 | -853074 USD | ? USD |
| 2010 | 623645 USD | ? USD |
| 2009 | -2.8 million USD | ? USD |
| 2008 | -4.3 million USD | ? USD |
| 2007 | -12.0 million USD | ? USD |
| 2006 | -9.7 million USD | ? USD |
| 2005 | -19.1 million USD | ? USD |
| 2004 | -5.9 million USD | ? USD |
| 2003 | -6.0 million USD | ? USD |
| 2002 | -1.5 million USD | 500000 USD |
| 2001 | -1.7 million USD | 2.7 million USD |
| 2000 | -5.8 million USD | 5.4 million USD |
| 1999 | -2.4 million USD | 1.2 million USD |
| 1998 | -2.8 million USD | 3.0 million USD |
| 1997 | -5.2 million USD | 100000 USD |
| 1996 | -3.6 million USD | 100000 USD |
TGTX
Price: $16.42
52 week price:
Earnings Per Share: 0.09 USD
P/E Ratio: -80.79
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.7 million
Ebitda: -31.6 millionMarket Capitalization: 2.3 billion